ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 237 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,546 | -13.0% | 650 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $15,568 | +27.3% | 650 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $12,233 | +18.2% | 650 | 0.0% | 0.01% | +25.0% |
Q4 2022 | $10,348 | -5.9% | 650 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $11,000 | +22.2% | 650 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $9,000 | -43.8% | 650 | 0.0% | 0.00% | -20.0% |
Q1 2022 | $16,000 | +6.7% | 650 | 0.0% | 0.01% | +25.0% |
Q4 2021 | $15,000 | +36.4% | 650 | 0.0% | 0.00% | +33.3% |
Q3 2021 | $11,000 | -31.2% | 650 | 0.0% | 0.00% | -25.0% |
Q2 2021 | $16,000 | -5.9% | 650 | 0.0% | 0.00% | -20.0% |
Q1 2021 | $17,000 | -51.4% | 650 | 0.0% | 0.01% | -54.5% |
Q4 2020 | $35,000 | -98.3% | 650 | -96.3% | 0.01% | -98.7% |
Q3 2020 | $2,025,000 | +6432.3% | 17,470 | +2587.7% | 0.85% | +6461.5% |
Q2 2020 | $31,000 | +14.8% | 650 | 0.0% | 0.01% | -23.5% |
Q1 2020 | $27,000 | -3.6% | 650 | 0.0% | 0.02% | +54.5% |
Q4 2019 | $28,000 | +21.7% | 650 | 0.0% | 0.01% | -8.3% |
Q3 2019 | $23,000 | +35.3% | 650 | 0.0% | 0.01% | +20.0% |
Q2 2019 | $17,000 | 0.0% | 650 | 0.0% | 0.01% | -16.7% |
Q1 2019 | $17,000 | +54.5% | 650 | 0.0% | 0.01% | +50.0% |
Q4 2018 | $11,000 | -15.4% | 650 | 0.0% | 0.01% | +33.3% |
Q3 2018 | $13,000 | +30.0% | 650 | 0.0% | 0.01% | +50.0% |
Q2 2018 | $10,000 | -33.3% | 650 | 0.0% | 0.00% | -33.3% |
Q1 2018 | $15,000 | -25.0% | 650 | 0.0% | 0.01% | -25.0% |
Q4 2017 | $20,000 | -16.7% | 650 | 0.0% | 0.01% | -27.3% |
Q3 2017 | $24,000 | +33.3% | 650 | 0.0% | 0.01% | +37.5% |
Q2 2017 | $18,000 | -18.2% | 650 | 0.0% | 0.01% | -27.3% |
Q1 2017 | $22,000 | +15.8% | 650 | 0.0% | 0.01% | +22.2% |
Q4 2016 | $19,000 | -55.8% | 650 | -50.0% | 0.01% | -66.7% |
Q3 2015 | $43,000 | +4.9% | 1,300 | 0.0% | 0.03% | +35.0% |
Q4 2014 | $41,000 | – | 1,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 556,553 | $11,598,565 | 5.78% |
Baker Brothers Advisors | 42,864,612 | $893,298,514 | 5.15% |
RTW INVESTMENTS, LP | 11,576,537 | $241,255,031 | 5.09% |
Palo Alto Investors LP | 2,405,793 | $50,136,726 | 4.74% |
Birchview Capital, LP | 240,400 | $5,009,936 | 4.26% |
EcoR1 Capital, LLC | 5,991,479 | $124,862,422 | 4.21% |
EMERALD ADVISERS, LLC | 1,681,052 | $35,033,124 | 1.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 1,303,988 | $27,175,110 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 179,702 | $3,739,599 | 1.26% |
SECTOR GAMMA AS | 179,785 | $3,746,719 | 0.96% |